Drug intelligence / Profile preview

caprylic alcohol

Development stage: Phase 2
Modality: Small Molecules
Administration: Oral

Overview

Caprylic alcohol, also known as 1-octanol, is a long-chain primary alcohol with the molecular formula C8H18O. It has been investigated for its potential to alleviate symptoms of essential tremor (ET) without causing intoxication or other significant adverse effects. The mechanism of action is not fully established but may involve its metabolite octanoic acid. Caprylic alcohol is also used industrially as an anti-foaming agent and chemical intermediate[1][2][8].

Other names: 1-octanol

Targets

Biological membrane

Beyond the preview

Go deeper on caprylic alcohol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on caprylic alcohol.

Explore the full profile